@article{article, title  = {{Safety, tolerability, and initial efficacy of AZD6140, the first reversivle oral adenosine diphosphate receptor antagonist, compared with clopidigrel, in patients with non-ST-segment elevation acute coronary syndrome - Primary results of the DISPERSE-2 trial}},

 url = {{}},

 year = {{2007}},

 month = {{11}},

 author = {{Cannon CP and Husted S and Harrington RA and Scirica BM and Emanuelsson H and Storey RF and DISPERSE-2 Invest}},

 doi = {{10.1016/j.jacc.2007.07.053}},

 volume = {{50}},

 journal = {{J AM COLL CARDIOL}},

 issue = {{19}},

 pages = {{1844-1851}},

 note = {{Accessed on 2024/12/28}}}